
# 🧬 EGFR Inhibition by Erlotinib — Molecular Docking Project

This repository contains a structural bioinformatics project demonstrating how **Erlotinib**, a cancer drug, binds to the **Epidermal Growth Factor Receptor (EGFR)**, a tyrosine kinase commonly mutated in cancers.

## 🎯 Objective
To simulate and analyze the interaction between EGFR and Erlotinib using molecular docking and structure-based modeling tools.

---

## 📁 Files Included

### 🔹 Project Archive
- [`TyrosineKinaseEGFRErlotinib.zip`](TyrosineKinaseEGFRErlotinib.zip) — Contains:
  - `receptor.pdb` – EGFR protein structure
  - `ligand.pdb` – Erlotinib ligand structure
  - `result.dock4` – Docking results file
  - `*.psf`, `*.crd`, `*.rtf`, `*.par` – Files for molecular simulations (CHARMM/NAMD)

---

## 🧪 Tools Likely Used
- **Docking**: AutoDock / DOCK
- **Molecular Simulations**: NAMD or CHARMM
- **Visualization**: PyMOL / VMD

---

## 📈 Output
- `result.dock4` contains docking scores and binding poses of Erlotinib with EGFR.
- Structures ready for further simulation or interaction analysis.

---

## 📌 How to Use
1. Download and unzip the `TyrosineKinaseEGFRErlotinib.zip` file.
2. Visualize structures using **PyMOL** or **VMD**.
3. Review `result.dock4` to analyze binding results.
4. Run simulations using tools like **NAMD** if desired.

---

## 📂 Folder Preview
```
TyrosineKinaseEGFRErlotinib/
├── files/
│   ├── receptor.pdb
│   ├── ligand.pdb
│   ├── receptor.psf
│   ├── receptor.crd
│   ├── extra.rtf
│   └── extra.par
├── result.dock4
└── parameters
```

---

## 📚 Notes
This is a **portfolio-level project** demonstrating structure-based drug discovery basics using a known kinase inhibitor.

---

*Feel free to fork, reuse, or expand this project for academic or personal learning purposes.*
